Critical Analysis of the Applicability of Small Bowel Capsule Endoscopy Performance Measures among 2 Portuguese Centers with Different Capsule Endoscopy Platforms

• Published in: GE Portuguese journal of gastroenterology Vol. 30; no. 3; pp. 230 - 238
• Main Authors: Gomes, Catarina, O’Neill, Catarina, Pinho, Rolando, Barosa, Rita, Ponte, Ana, Magalhães-Costa, Pedro, Rodrigues, Adélia, Chagas, Cristina, Carvalho, João
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01-06-2023; Karger Publishers
• Subjects: Biopsy; Crohns disease; Data collection; endoscopic units; Endoscopy; Patients; performance measures; Polyethylene glycol; Quality improvement; Quality standards; Research Article; Retention; small bowel capsule endoscopy; Statistical analysis; Working groups; Small bowel capsule endoscopy; Performance measures; Endoscopic units
• ISSN: 2341-4545; 2387-1954
• DOI: 10.1159/000523773

Abstract
Introduction: The European Society of Gastrointestinal Endoscopy (ESGE) identified the need to benchmark the quality of small bowel capsule endoscopy (SBCE) and produced a set of performance measures (PM). The aim of this study is to critically evaluate the accordance of the PM for SBCE in two Portuguese centers with different SBCE platforms. Methods: The authors conducted a cross-sectional analysis of consecutive SBCE performed in an 18-month period in 2 Portuguese centers that used two different SBCE platforms Mirocam® (IntroMedic, Seoul, South Korea) and PillCam® (Medtronic, Yokneam, Israel). A total of 10 PM (6 key, 4 minor) were evaluated and compared between the 2 centers. Results: A total of 493 SBCE were included. The minimum standard established by ESGE was reached in 3/6 key PM (complete visualization, lesion detection rate, and capsule retention rate), and none of the 4 minor PM. PM compliance significantly differed between the 2 centers: complete small bowel visualization 95.9 and 90% (p = 0.01), diagnostic yield 50.6 and 63% (p = 0.005), adequate small bowel cleansing level according to Brotz scale 69.54 and 84.6% (p ≤ 0.001), patients with high risk of capsule retention offered a patency capsule 4.2 and 73% (p ≤ 0.001), respectively. Conclusion: This study highlights and critically discusses technical and organizational issues that should be considered in defining more realistic PM thresholds, aiming to improve SBCE quality.